Seagen (SGEN) Competitor Comparison
We are evaluating the key criteria listed to compare Seagen (SGEN) against its competitors in the Biotechnology industry.
Market Capitalization
3 / 368Gross Profits
29 / 278Total Revenue
8 / 300EBITDA
332 / 337Free Cashflow
335 / 352Quick Ratio
293 / 357Earnings per Share
283 / 359Dividend yield
0 / 6Total Cash
17 / 358Performance 3 years
81 / 368Performance 5 years
26 / 368Performance 10 years
22 / 368Linearity 3 years
44 / 368Linearity 5 years
335 / 368Linearity 10 years
367 / 368Total Rank
260 / 368Dividend Rank
269 / 368Valuation Rank
259 / 368Piotroski Rank
142 / 368Muliplier Rank
204 / 368Total Cash - SGEN ranking 17 / 358
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.